Stay updated on Mylan Insulin Glargine Safety Clinical Trial
Sign up to get notified when there's something new on the Mylan Insulin Glargine Safety Clinical Trial page.

Latest updates to the Mylan Insulin Glargine Safety Clinical Trial page
- Check4 days agoChange DetectedAdded a Locations section and included state listings (California, Colorado, Florida, Georgia, Idaho, Illinois, Iowa, Texas); removed the individual California, Colorado, Florida, Georgia, Idaho, Illinois, Iowa, and Texas Location subsections. The page revision was updated to v3.3.3 (replacing v3.3.2) and the HHS Vulnerability Disclosure link was removed.SummaryDifference0.8%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page shows a revision update from v3.3.1 to v3.3.2. No substantive changes to the study details or page content are visible.SummaryDifference0.0%

- Check32 days agoChange DetectedThe page now shows a revision label: Revision: v3.3.1, replacing the previous Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedA government funding/operational-status notice was removed from the page.SummaryDifference0.3%

- Check54 days agoChange DetectedNo significant changes detected; the page content remains consistent with the prior state.SummaryDifference0.4%

- Check83 days agoChange DetectedMajor update to core page content: adds a government funding notice and current operating status details, plus a version bump to v3.2.0; removes the previous v3.1.0 reference.SummaryDifference3%

Stay in the know with updates to Mylan Insulin Glargine Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mylan Insulin Glargine Safety Clinical Trial page.